Protective Role of Agomelatine via Modulation of TLR4/NF-κB: NLRP3/IL-1β Signaling Pathways in Testosterone-Induced Benign Prostatic Hyperplasia in Rats

    Asmaa Mohamed Abdel‐Aziz, Sara M. Ahmed, Walaa Yehia Abdelzaher, Nada Amgad Mohamed, Alyaa E. Abdelkader, Rasha F. Ahmed, Asmaa Ali, Ahmed Kotb, Alyaa Abdelfattah Abdelmonaem
    Image
    Studysummary In this animal study, AGO (agomelatine) effectively alleviated testosterone-induced benign prostatic hyperplasia in rats by reducing oxidative stress and inflammation, indicating its potential as a therapeutic option for managing BPH through specific signaling pathways.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results